What this means
Researchers plan to compare Vitamin C with a placebo pill in women with ovarian aging. The study has not started taking people yet, so no results exist.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- See eligibility
- Where
- Not listed
The science
- Registered title
- Therapeutic Effect of Vitamin C Supplementation in Patients With Ovarian Aging
- Trial ID
- NCT06794060 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Premature Ovarian Insufficiency, Ovarian Reserve Function
- What is tested
- Vitamin C (Ascorbic Acid), Vitamin C (Ascorbic Acid), Placebo
- Sponsor
- Peking University Third Hospital
- Ages
- No minimum to no maximum
- Dates
- First posted Jan 27, 2025 · updated Jun 26, 2025
Registry summary
The goal of this clinical trial is to learn if Vitamin C works to improve ovarian reserve in women with ovarian aging. It will also learn about the safety of Vitamin C. The main questions it aims to answer are:
- Does Vitamin C supplementation improve the ovarian reserve prediction score?
- What medical problems do participants have when taking Vitamin C supplementation?
Researchers will compare Vitamin C to a placebo (a look-alike substance that contains no drug) to see if drug Vitamin C works to improve ovarian reserve in women with ovarian aging. Participants will:
- Take Vitamin C or a placebo every day for 12 months
- Visit the clinic once every 4 weeks for follow-up and drug distribution.
- Return the Vitamin C box at each visit.
- Report any adverse effects of treatment to the doctor.
- Fill out a questionnaire at each visit.
- After 6 months and 12 months of intervention, take blood test and ultrasonic examination.